Skip Nav Destination
Issues
1 August 2016
-
Cover Image
Cover Image
The current study uses integrated genomics to reveal markers that may provide guidance for better treatment of vulvar cancer. One such marker, GNB3 (G Protein Subunit Beta 3), appears in vulvar carcinoma as a new and potential prognostic factor since its up-regulation in tumors is associated mainly with higher disease-free survival. The cover image shows GNB3 immunohistochemistry (IHC) staining in adjacent normal tissue showing predominantly low staining in basal layers of the epithelium. For more information, see the article by Lavorato-Rocha and colleagues beginning on page 720. - PDF Icon PDF LinkTable of Contents
ISSN 1541-7786
EISSN 1557-3125
Molecular Cancer Research
Table of Contents
Highlights
Perspective
Cell Cycle and Senescence
Cell Death and Survival
Author Choice
Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis
Elizabeth A. Stanford; Alejandra Ramirez-Cardenas; Zhongyan Wang; Olga Novikov; Khalid Alamoud; Petros Koutrakis; Joseph P. Mizgerd; Caroline A. Genco; Maria Kukuruzinska; Stefano Monti; Manish V. Bais; David H. Sherr
Chromatin, Epigenetics, and RNA Regulation
GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome
Diana C. West; Deng Pan; Eva Y. Tonsing-Carter; Kyle M. Hernandez; Charles F. Pierce; Sarah C. Styke; Kathleen R. Bowie; Tzintzuni I. Garcia; Masha Kocherginsky; Suzanne D. Conzen
Genomics
An Integrative Approach Uncovers Biomarkers that Associate with Clinically Relevant Disease Outcomes in Vulvar Carcinoma
Andre M. Lavorato-Rocha; Erica M. Akagi; Beatriz de Melo Maia; Iara S. Rodrigues; Mayara Caroline Silva Botelho; Fabio A. Marchi; Gabriel Fernandes; Glauco Baiocchi; Fernando A. Soares; Silvia Regina Rogatto; Yukie Sato-Kuwabara; Rafael M. Rocha
Oncogenes and Tumor Suppressors
Signal Transduction
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.